01952 EVEREST MED-B
- 23.500
- -0.300-1.26%
EVEREST MED-B News
EVEREST MED-B: UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION - (1) COLLABORATION AND LICENSE AGREEMENT; AND (2) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN LICENSED PRODUCTS
EVEREST MED-B: (1) MAJOR TRANSACTION IN RELATION TO THE TERMINATION AND TRANSITION SERVICES AGREEMENT; AND (2) NOTICE OF EXTRAORDINARY GENERAL MEETING
EVEREST MED-B: DALAY IN DESPATCH OF CIRCULAR
EVEREST MED-B: (1) MAJOR TRANSACTION IN RELATION TO THE TERMINATION AND TRANSITION SERVICES AGREEMENT AND (2) CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
EVEREST MED-B: DISCLOSEABLE TRANSACTION - PATENT AND KNOW-HOW LICENSE AGREEMENT WITH A*CCELERATE
EVEREST MED-B: DISCLOSEABLE TRANSACTION - LICENSE AGREEMENT FOR GLOBAL DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF NOVEL BTK INHIBITOR IN RENAL DISEASES
Analysis
Price Target
No Data
